MedTrace Logo

HPV Integration Testing for Human Papillomavirus-Positive Women

NCT02576262 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2017-06-27

No results posted yet for this study

Summary

Papanicolaou (Pap) triage, with high specificity, has been recommended for primary Human papillomavirus (HPV) testing but is flawed by poor sensitivity and cytologist dependence. the investigators evaluated the potential role of HPV Integration detection in cervical exfoliated cells in HPV-positive women from a clinic-based population.

Conditions

Interventions

PROCEDURE

TCT，HPV，colposcopic inspection

Sponsors & Collaborators

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Ding Ma, MD, PhD · Huazhong University of Science and Technology

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-09-30
Completion
2020-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02576262 on ClinicalTrials.gov